At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.
The PositionIn Roche’s Pharmaceutical Research and Early Development organization (pRED), we focus on the discovery and early clinical development of innovative treatments for some of the world’s toughest unmet healthcare needs.
pRED Infectious Diseases focuses on the discovery and early development of innovative treatments for specific diseases that affect the lives of millions.
The Antibiotic Discovery Group at Roche Pharma Research and Early Development (pRED) is dedicated to the discovery and development of novel anti-infective agents for treating multidrug-resistant bacterial infections.
The OpportunityWe are seeking a highly motivated early-career scientist to join our diverse and global team!
Key responsibilities:
Independently perform and coordinate experiments and studies supporting the discovery and development of novel class antibiotics.
Provide biological expertise to support the development of molecules in the preclinical and clinical stages
Provide biochemical and/or genomics support on molecular target validation/mechanism of action identification and resistance assessment of the targeted pathogens versus new antimicrobial agents
Serve as an integral member of a diverse team of scientists involved in the discovery and development of novel anti-infective agents for the treatment of multidrug-resistant bacterial infections
You are a passionate early-career scientist eager to advance anti-infective research and deliver new antibiotic solutions against multidrug-resistant pathogens within a dynamic, global team.
You hold a PhD in Microbiology, Biochemistry, or Molecular Biology, supported by at least three years of postdoctoral experience specializing in anti-infective agents and genomics.
You bring in-depth technical experience in one or more of the following domains: NGS data analysis (short- and long-read), biochemical assay development, and/or clinical microbiology techniques.
You are adept at managing collaborations with CROs and demonstrate strong teamwork, communication, and presentation skills while maintaining fluency in English.
You combine a solid foundation in microbiology with a desire to support molecules through preclinical and clinical stages, with any computational biology or programming skills being a distinct plus.
Unwavering focus, collaborative teamwork and exceptional delivery are key behaviours that drive our mission of doing now what patients need next. Together, we can be transformative.
If you are passionate about contributing to a committed team and have the dedication to partnership and innovation, Roche is the place for you!
Every role at Roche plays a part in making a difference in patients’ lives. Apply now and join us in making an impact!
Who we are
A healthier future drives us to innovate. Together, more than 100’000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life-changing healthcare solutions that make a global impact.
Let’s build a healthier future, together.
Roche is an Equal Opportunity Employer.
Roche Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Roche and has not been reviewed or approved by Roche.
-
Retirement Support — U.S. materials describe a 401(k) with both matching and an additional company contribution, supported by formal plan documents and true‑up features. This structure is positioned as a standout element of the total package, particularly at Genentech.
-
Leave & Time Off Breadth — Time‑off provisions include substantial vacation, a year‑end shutdown, and a paid six‑week sabbatical after six years. These elements indicate a recharge‑oriented approach within the U.S. offering.
-
Healthcare Strength — Company materials emphasize comprehensive medical, dental, vision, and mental‑health resources alongside well‑being programs. Benefits pages consistently highlight breadth across core health coverage elements.
Roche Insights
Similar Jobs
What We Do
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).







